1Johannessen SI, Battino D, Berry DJ, et al. Therapeutic drug monitoring of the newer antiepileptic drugs[J]. Ther Drug Monit, 2003, 25(3):347-363. 被引量：1
2Hirose S, Okada M, Kaneko S, et al. Are some idiopathic epilepsies disorders of ion channels? : A working hypothesis[J]. Epilepsy Res, 2000, 41 (3): 191-204. 被引量：1
3Steinlein OK. Genes and mutations in human idiopathic epilepsy[J]. Brain Dev, 2004, 26(4):213-218. 被引量：1
4Lenzen KP, Hells A, Lorenz S, et al. Supportive evidence for an allelic association of the human KCNJ10 potassium channel gene with idiopathic generalized epilepsy[J]. Epilepsy Res, 2005, 63(2-3) :13-118. 被引量：1
6Tate SK, Depondt C, Sisodiya SM et al. Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin. [J] PNAS, 2005, 102 (15): 5507-5512. 被引量：1
7Remy S, Gabriel S, Urban BW, et al. A novel mechanism underlying drug resistance in chronic epilepsy. [J]Ann Neurol, 2003, 53(4):469-479. 被引量：1
8Anderson GD. Pharmacogenetics and enzyme induc tion/inhibition properties of antiepileptic drugs [J]. Neurology, 2004, 63(Suppl 4): S3-S8. 被引量：1
9Komatsu T, Yamazaki H, Asahi S, et al. Formation of a dihydroxy netabolite of phenytoin in human liver microsomes/cytosol: roles of cytochromes P450 2C9,2C19, and 3A4. [J]. Drug Metab Dispos, 2000, 28 (11):1361-1368. 被引量：1
10Rettie AE, Haining RL, Bajpai M, et al. A common genetic basis for idiosyncratic toxicity of warfarin and phenytoin[J]. Epilepsy Res, 1999, 35:253-255. 被引量：1
3FENG H J, HUANG S L,WANG W,et al. The induction effect of rifampicin on activity of mephenytoin 4' - hydroxylase related to M1mutation of CYP2C19 and gene dose[J ]. Br J Clin Pharmacol, 1998,45:27-29. 被引量：1
4XIE H G, STEIN C M,KIM R B, et al. Wood AJ (1999). Frequency of functionally important beta- 2 adrenoceptor polymorphisms varies markedly among African- American, Caucasian and Chinese individuals[J]. Pharmacogenetics, 1999(9) :511 - 516. 被引量：1
5ZHOU H H,KOSHAKJI R P,Silberstein D J ,et al. Racial differences in drug response: Altered sensitivity to and clearance of propranolol in men of Chinese descent as compared with American Whites[J]. N Eng J Med, 1989,320:565 - 570. 被引量：1
6ZHOU H H,SILBERSTEIN D J, KOSHAKJI R P,WOODA J J. Interindividual differences in beta- receptor density contribute to variability in response to beta- adrenoceptor antagonists[J]. Clin Pharmacol Ther. 1989,45:587-592. 被引量：1
7ZHOU H H,ADEDOYIN A, WILKINSON G R. Differences in plasma binding of drug between Caucasians and Chinese[J]. Clin Pharmacol Ther, 1990.48:10-17. 被引量：1
8WOOD AJJ, ZHOU H H. Ethnic differences in drug responses[J].Clin Pharmacokin, 1991,20: 350 - 373. 被引量：1
9XIE H G, XU Z H, LUO X, et al. Genetic polymorphisms of debrisoquine and S - mephenytoin oxidation metabolm in Chinese populations: a meta- analysis[J]. Pharmacogenetics, 1996(6) :235 - 238. 被引量：1
10XIE HG,XUZH,OU-YANGDS,etal. Meta-analysisofphenotypeand genotype of NAT2 deficiency in Chinese populations[J ]. Pharmacogenetics, 1997,7:503 - 514. 被引量：1
